SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Anand, P., Kunnumakkara, A. B., Newman, R. A., and Aggarwal, B. B. (2007) Bioavailability of curcumin: Problems and promises. Mol. Pharm. 4, 807818.
  • 2
    Kelloff, G. J., Crowell, J. A., Hawk, E. T., Steele, V. E., Lubet, R. A., et al. (1996) Strategy and planning for chemo preventive drug development: clinical development plans II. J. Cell. Biochem. 63, 5471.
  • 3
    Rao, C. V., Rivenson, A., Simi, B., and Reddy, B. S. (1995) Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res. 55, 259266.
  • 4
    Kawamori, T., Lubet, R., Steele, V. E., Kelloff, G. J., Kaskey, R. B., et al. (1999) Chemopreventative effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res. 59, 597601.
  • 5
    Piper, J. T., Singhal, S. S., Salameh, M., Torman, R. T., Awasthi, Y. C., et al. (1998) Mechanisms of anticarcinogenic properties of curcumin: the effect of curcumin on glutathione linked detoxification enzymes in rat liver. Int. J. Biochem. Cell Biol. 30, 445456.
  • 6
    Susan, M. and Rao, M. N. A. (1992) Induction of glutathione S-transferase activity by curcumin in mice. Arzneimittel-Forschung (Drug Res.). 42, 962964.
  • 7
    Jovanovic, S. V., Steenken, S., Boone, C. W., and Simic, M. G. (1998) H-Atom transfer is a preferred antioxidant mechanism of curcumin. J. Am. Chem. Soc. 121, 96779681.
  • 8
    Sharma, R. A., Ireson, C. R., Verschole, R. D., Hill, K. A., Williams, M. L., et al. (2001) Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa relationship with drug levels. Clin. Cancer Res. 7, 14521458.
  • 9
    Sharma, R. A., Euden, S. A., Platton, S. L., Cooke, D. N., Shafayat, A., et al. (2004) Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin. Cancer Res. 10, 68476854.
  • 10
    Midura-Kiela, M. T., Radhakrishnan, V. M., Larmonier, C. B., Laubitz, D., Ghishan, F. K., et al. (2012) Curcumin inhibits interferon-γ signaling in colonic epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G85G96.
  • 11
    Singh, R. and Sharma, P. (2011) Hepatoprotective effect of curcumin on lindane-induced oxidative stress in male Wistar rats. Toxicol. Int. 18, 124129.
  • 12
    NCI. (1996) Clinical development plan: curcumin. J. Cell. Biochem. Suppl. 26, 7285.
  • 13
    Heath, D. D., Pruitt, M. A., Brenner, D. E., and Rock, C. L. (2003) Curcumin in plasma and urine: quantitation by high-performance liquid chromatography. J. Chromatogr. B 783, 287295.
  • 14
    Kurien, B. T., Singh, A., Matsumoto, H., and Scofield, R. H. (2007) Improving the solubility and pharmacological efficacy of curcumin by heat treatment. Assay Drug Dev. Technol. 5, 567576.
  • 15
    Kurien, B. T. and Scofield, R. H. (2007) Curcumin/turmeric solubilized in sodium hydroxide inhibits HNE protein modification—an in vitro study. J. Ethnopharmacol. 110, 368373.
  • 16
    Rezq, A., Aziz, A., Talaat, M., and Kumosani, T. A. (2010) PCT/EG2008/000044, Published Patent Pending, WO 2010/057503, Regional phase European Patent Application No. 08878223.
  • 17
    Rezq, A., Aziz, A., Talaat, M., and El-Malki, A. (2011) PCT/EG2010/000008, Published Patent Pending, WO 2011/100984 Indian National phase application No. 8081/DLNP/2012.
  • 18
    Habig, W. H., Pabst, M. J., and Jakoby, W. B. (1974) Glutathione S-transferases. J. Biol. Chem. 249, 71307139.
  • 19
    Hanafy, K. A., Krumenacker, J. S., and Murad. F. (2001) NO, nitrotyrosine, and cyclic GMP in signal transduction. Med. Sci. Monit. 7, 801819.
  • 20
    Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265275.
  • 21
    Abraham, N. G., Lin, J. H., Schwartzman, M. L., Levere, R. D., and Shibahara, S. (1988) The physiological significance of heme oxygenase. Int. J. Biochem. 20, 543558.
  • 22
    Abdel Aziz, M. T., El Asmer, M. F., Rezq, A., Kumosani, T. A., Mostafa, S., et al. (2010) Novel water soluble curcumin derivative mediates erectile signaling. J. Sex. Med. 7, 27142722.
  • 23
    Abdel Aziz, M. T., Mostafa, T., Atta, H., Rashed, L., Marzouk, S. A., et al. (2008) The role of PDE5 inhibitors in heme oxygenase-cGMP relationship in rat cavernous tissues. J. Sex. Med. 5, 16361645.
  • 24
    Abdel Aziz, M. T., Mostafa, T., Atta, H., Wassef, M. A., Fouad, H. H., et al. (2009) Putative role of carbon monoxide signaling pathway in penile erectile function. J. Sex. Med. 6, 4960.
  • 25
    Abdel-Aziz, M. T., Al-Asmar, M. F., Atta, H., Shaker, O., Fouad, H., et al. (2002) Effect of inducers of heme oxygenase-1 on eicosanoids, cAMP, cGMP levels in rat endothelial cells. Biochim. Clin. 26, 352357.
  • 26
    Abdel-Aziz, M. T., El-Asmar, M. F., Mostafa, T., Atta, H., Abdel Aziz, M., et al. (2005) Effects of nitric oxide synthase and heme oxygenase inducers and inhibitors on molecular signaling of erectile function. J. Clin. Biochem. Nutr. 37, 103111.
  • 27
    Abdel Aziz, M. T., Mostafa, T., Atta, H., Rashed, L., Marzouk, S. A., et al. (2007) Oral phosphodiesterase-5 inhibitors: effect of heme oxygenase inhibition on cGMP signaling in rat cavernous tissue. Andrologia 39, 6670.
  • 28
    Abdel Aziz, M. T., Abraham, N., Mostafa, T., Mahfouz, S., Atta, H., et al. (2008) Heme oxygenase-1 (HO-1) gene transfer and CORM-3 as therapeutic modalities in erectile dysfunction. Andrologia 5, 363343.
  • 29
    Abdel Aziz, M. T., El-Asmer, M. F., Mostafa, T., Mostafa, S., Atta, H., et al. (2007) Heme oxygenase versus nitric oxide synthase in signaling mediating sildenafil citrate action. J. Sex. Med. 4, 10981107.
  • 30
    Schini-Kerth, V. B., Auger, C., Étienne-Selloum, N., and Chataigneau, T. (2010) Polyphenol-induced endothelium-dependent relaxations. Role of NO and EDHF. Adv. Pharmacol. 60, 136175.
  • 31
    Xu, P. H., Long, Y., Dai, F., and Liu, Z. L. (2007) The relaxant effect of curcumin on porcine coronary arterial ring segments. Vascul. Pharmacol. 47, 2530.
  • 32
    Abusnina, A., Keravis, T., Yougbaré, I., Bronner, C., and Lugnier, C. (2011) Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1. Mol. Nutr. Food Res. 55, 16771689.
  • 33
    Yang, C., Zhang, X., Fan, H., and Liu, Y. (2009) Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Res. 1282, 133141.
  • 34
    Lee, J. S. and Surh, Y. J. (2005) Nrf2 as a novel molecular target for chemoprevention. Cancer Lett. 224, 171184.
  • 35
    Giudice, A., Arra, C., and Turco, M. C. (2010) Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents. Methods Mol. Biol. 647, 3774.
  • 36
    Plummer, S. M., Hill, K. A., Festing, M. F. W., Steward, W. P., Gescher, A. J., et al. (2001) Clinical development of leukocyte cyclooxygenase-2 activity as a systemic biomarker for cancer chemopreventive agents. Cancer Epidemiol. Biomarkers Prev. 10, 12951299.
  • 37
    Dinkova-Kostova, A. T. and Talalay, P. (1999) Relation of structure of curcumin analogs to their potencies as inducers of phase 2 detoxification enzymes. Carcinogenesis 20, 911914.